A minimally invasive approach to nasal airway obstruction.
Ventra™ is an investigational device being developed to remodel the nasal airway and improve airflow by addressing structural obstruction caused by septal deviation and inferior turbinate enlargement through a minimally invasive ENT procedure.
AeroVia presents its flagship Ventra™ solution, a purpose-built ENT system, designed around the anatomy and the procedure it serves.
AeroVia Medical™ is a medical technology company developing an ENT solution driven by addressing an unmet procedural need shaped from extensive clinical insight and engineered with precision.
Making a real-world impact on healthcare systems through the introduction of an innovative new technique in the treatment of nasal obstruction.
Ventra™ is designed to be a disruptor in the surgical space, directly challenging a century-old treatment for nasal obstruction. It replaces surgical intervention performed under general anaesthesia and transforms that into an in-office, local anaesthetic procedure with minimal downtime and quicker recovery for the patient.
Ventra™ is currently in pre-clinical development, with cadaveric validation underway. From its earliest stages, the programme has been shaped by guidance from leading ENT KOLs, who together form AeroVia Medical™’s Medical Advisory Board. AeroVia also benefits from the support of key strategic partners as we progress toward first-in-human studies and future commercialisation.
We always welcome conversations from clinicians, strategic partners and investors who share our focus on advancing ENT procedural care.
Designed around the procedure
Developed with attention to anatomical fit, procedural handling and practical workflow in ENT settings.
Surgeon-led
Informed by clinical input to ensure the system reflects real procedural needs, not just device design assumptions.
Built for the pathway
Being developed with regulatory, quality and clinical validation requirements in mind from an early stage.
Designed to create space where nasal airflow is restricted.
Ventra™ is a balloon-catheter system being developed for ENT procedures involving the lower nasal airway, including the septum and inferior turbinate. It is intended for use by qualified clinicians in a controlled procedural setting.
The system has been shaped by a clear clinical observation: nasal obstruction is often structural, but current surgical options can be invasive, technically demanding, and resource-intensive. Ventra™ is developed to offer a more focused procedural approach, designed around the anatomy and the workflow of ENT practice.
Its purpose is simple: to support clinicians in addressing nasal airway obstruction through a carefully designed, minimally invasive system.
Get in touch.
We always welcome conversations from clinicians, strategic partners and investors.